scholarly journals P86.02 Pyrotinib Combined with Apatinib for HER2-Mutant Non-Small Cell Lung Cancer: Interim Analysis from a Phase II Clinical Study

2021 ◽  
Vol 16 (3) ◽  
pp. S672-S673
Author(s):  
G. Yang ◽  
H. Xu ◽  
F. Xu ◽  
L. Yang ◽  
H. Li ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Study ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Interim Analysis ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase Ii Clinical Study

A phase II clinical study of suramin in combination with mitomycin C in patients with non small cell lung cancer

Lung Cancer ◽  
1991 ◽  
Vol 7 (5) ◽  
pp. 323-328 ◽  
Author(s):  
Bernardo Leon Rapoport ◽  
Geoffrey Falkson ◽  
Stephen Maxted Ansell ◽  
Barend Petrus Lotz ◽  
Magriet de Wet
Keyword(s):  
Lung Cancer ◽  
Clinical Study ◽  
Small Cell Lung Cancer ◽  
Mitomycin C ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase Ii Clinical Study

Weekly docetaxel as II line therapy in non-small cell lung cancer: an interim analysis of a phase II study

Lung Cancer ◽  
2001 ◽  
Vol 34 ◽  
pp. 31-35 ◽  
Author(s):  
Maria Rosaria Valerio ◽  
Antonio Russo ◽  
Mario Adelfio Latteri ◽  
Giuseppe Modica ◽  
Gaspare Gulotta ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Interim Analysis ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Weekly Docetaxel ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document